Helocyte, Inc. announced it raised $1 Million in an initial filing from an offering of $5 Million

Jul 15, 2016•almost 9 years ago

Amount Raised

$1 Million

Round Type

seed

New YorkBiotechnology

Company Information

Company

Helocyte, Inc.

Location

2 GANSEVOORT STREET

New York, New York, United States

About

Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.